These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 9553691

  • 1. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J, Kist A, Stremmel W, Galle PR.
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [Abstract] [Full Text] [Related]

  • 2. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line.
    Hajnická V, Fuchsberger N, Liptáková H, Stancek D, Kontsek P.
    Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013
    [Abstract] [Full Text] [Related]

  • 3. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.
    Wang Y, Wei L, Jiang D, Cong X, Fei R, Chen H, Xiao J, Wang Y.
    Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C.
    Antivir Ther; 2009 Aug; 14(1):131-5. PubMed ID: 19320247
    [Abstract] [Full Text] [Related]

  • 5. Cytokine inhibition of the hepatitis B virus core promoter.
    Romero R, Lavine JE.
    Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037
    [Abstract] [Full Text] [Related]

  • 6. Interferon-gamma, tumor necrosis factor-alpha, and interleukin 1-beta suppress the replication of hepatitis B virus through oxidative stress.
    Togashi H, Ohno S, Matsuo T, Watanabe H, Saito T, Shinzawa H, Takahashi T.
    Res Commun Mol Pathol Pharmacol; 2000 Jan; 107(5-6):407-17. PubMed ID: 11589367
    [Abstract] [Full Text] [Related]

  • 7. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
    Marinos G, Naoumov NV, Williams R.
    Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of hepatitis B virus polymerase-activity by various agents. Transient expression of hepatitis B virus DNA in hepatoma cells as novel system for evaluation of antiviral drugs.
    Galle PR, Theilmann L.
    Arzneimittelforschung; 1990 Dec; 40(12):1380-2. PubMed ID: 2095136
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the replication of hepatitis B virus in vitro by emodin.
    Shuangsuo D, Zhengguo Z, Yunru C, Xin Z, Baofeng W, Lichao Y, Yan'an C.
    Med Sci Monit; 2006 Sep; 12(9):BR302-6. PubMed ID: 16940925
    [Abstract] [Full Text] [Related]

  • 11. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE, Wei J, Huang Z, Huang C, Nalca A, Wells J, Russell J, Collins B, Ptak R, Lang W, Scribner C, Blanchett D, Alessi T, Langecker P.
    Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555
    [Abstract] [Full Text] [Related]

  • 12. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.
    Xiong W, Wang X, Liu XY, Xiang L, Zheng LJ, Liu JX, Yuan ZH.
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C, Rinaudo JA, Farrar K, Wells F, Korba BE.
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [Abstract] [Full Text] [Related]

  • 14. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
    Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ.
    Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
    [Abstract] [Full Text] [Related]

  • 15. [Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro].
    Cao H, Tao P.
    Zhonghua Yi Xue Za Zhi; 2001 Aug 25; 81(16):1004-7. PubMed ID: 11718074
    [Abstract] [Full Text] [Related]

  • 16. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L, Thabut D, Zoulim F, Andreani T, Chazouillères O, Carbonell N, Loria A, Poupon R.
    Hepatology; 2001 Sep 25; 34(3):573-7. PubMed ID: 11526544
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 25; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 18. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ.
    J Viral Hepat; 2006 Mar 25; 13(3):158-65. PubMed ID: 16475991
    [Abstract] [Full Text] [Related]

  • 19. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML.
    Antivir Ther; 2005 Mar 25; 10(1):125-33. PubMed ID: 15751770
    [Abstract] [Full Text] [Related]

  • 20. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.
    Shi H, Lu L, Zhang NP, Zhang SC, Shen XZ.
    World J Gastroenterol; 2012 Jul 21; 18(27):3617-22. PubMed ID: 22826629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.